Cita APA

Borràs, C., Canyelles, M., Girona, J., Ibarretxe, D., Santos, D., Revilla, G., . . . Escolà-Gil, J. C. (2024). PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia.

Citación estilo Chicago

Borràs, Carla|||0000-0002-0998-7855, et al. PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia. 2024.

Cita MLA

Borràs, Carla|||0000-0002-0998-7855, et al. PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia. 2024.